Tony Hagen

March 02, 2018

Experts focus on genetic abnormalities to advance cancer care.

December 08, 2017

Researchers find that women with postmenopausal hormone receptor (HR)-positive breast cancer may undergo shorter treatments of Arimidex, which may in turn cause less bone fractures.

December 07, 2017

The combination use of Herceptin plus standard adjuvant chemotherapy does not improve outcomes in women with HER2-low breast cancer.

November 29, 2017

As PARP inhibitors continue to improve outcomes in patients with ovarian cancer, they may one day be moved into the frontline treatment setting, said Susana M. Campos, M.D., a gynecologic oncologist at Dana-Farber Cancer Institute and an assistant professor at Harvard Medical School.

August 31, 2017

The newly approved CAR T-cell therapy, Kymriah (tisagenlecleucel), is being put on the market with a price tag of $475,000 for a single infusion, which is within the range that oncologists predicted.

July 19, 2017

“If you locked everybody in a room for a week, I think we could come up with something that everybody would be comfortable with,” said Blase Polite, M.D., a co-author of the statement, and immediate past chair of ASCO’s government relations committee.

June 19, 2017

Reforms are needed high up within the drug distribution chain, concluded a panel of pharmaceutical professionals at the Oncology Market Access & Pricing conference held in Philadelphia this week by eyeforpharma.

May 04, 2017

The American Health Care Act has been passed by a vote of 217 to 213.

April 06, 2017

Can President Donald Trump be more successful in lowering drug prices than he was in repealing and replacing the Affordable Care Act?

April 06, 2017

Tecentriq showed impressive long-term survival in patients with metastatic TNBC, according to the results from a recent study.